New indolyl peptidyl esters as MAO inhibitors.
D000700:Analgesics; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000201:enzymology; D066298:In Vitro Techniques; D007211:Indoles / Q000138:chemical synthesis* / Q000494:pharmacology; D008928:Mitochondria / Q000201:enzymology; D008930:Mitochondria, Liver / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000138:chemical synthesis* / Q000633:toxicity; D010455:Peptides / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D014191:Tranylcypromine / Q000494:pharmacology
D000700:Analgesics; D000928:Antidepressive Agents; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D010455:Peptides; D014191:Tranylcypromine; D012110:Reserpine